MedMira Inc Cash Flow Conversion Efficiency
MedMira Inc cash flow conversion efficiency. Based on the latest financial reports, MedMira Inc (MIR) has a cash flow conversion efficiency ratio of 0.006x as of April 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CA$-150.63K ≈ $-108.96K USD) by net assets (CA$-24.52 Million ≈ $-17.73 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of MedMira Inc (2000–2025)
Cash flow conversion efficiency of MedMira Inc from 2000 to 2025. This chart illustrates how MedMira Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. View MedMira Inc stock quote for real-time trading data and today's change.
MedMira Inc Cash Flow Conversion Ratio Explained
MedMira Inc cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
MedMira Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of MedMira Inc ranked by their cash flow conversion efficiency. Also see market cap of MedMira Inc for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Siab Holdings Bhd
KLSE:0241
|
0.563x |
|
Progressive Planet Solutions Inc
V:PLAN
|
0.088x |
|
Synertec Corporation Ltd
AU:SOP
|
0.100x |
|
ENPlus Co Ltd
KO:074610
|
-0.058x |
|
Reyna Silver Corp
V:RSLV
|
-0.053x |
|
Ruanyun Edai Technology Inc. Ordinary shares
NASDAQ:RYET
|
-0.058x |
|
Stria Lithium Inc
V:SRA
|
-0.053x |
|
Amoeba SA
PA:ALMIB
|
0.644x |
Annual Cash Flow Conversion Efficiency for MedMira Inc (2000–2025)
The table below shows the annual cash flow conversion efficiency of MedMira Inc from 2000 to 2025. Review how much free cash does MedMira Inc generate to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-07-31 | CA$-22.56 Million ≈ $-16.32 Million |
CA$-3.15 Million ≈ $-2.28 Million |
0.139x | -14.42% |
| 2024-07-31 | CA$-18.04 Million ≈ $-13.05 Million |
CA$-2.94 Million ≈ $-2.13 Million |
0.163x | +93.17% |
| 2023-07-31 | CA$-15.03 Million ≈ $-10.87 Million |
CA$-1.27 Million ≈ $-917.07K |
0.084x | -44.69% |
| 2022-07-31 | CA$-12.36 Million ≈ $-8.94 Million |
CA$-1.88 Million ≈ $-1.36 Million |
0.152x | +375.09% |
| 2021-07-31 | CA$-15.72 Million ≈ $-11.37 Million |
CA$-504.64K ≈ $-365.05K |
0.032x | +58.11% |
| 2020-07-31 | CA$-15.56 Million ≈ $-11.26 Million |
CA$-315.90K ≈ $-228.51K |
0.020x | -70.85% |
| 2019-07-31 | CA$-13.52 Million ≈ $-9.78 Million |
CA$-941.13K ≈ $-680.80K |
0.070x | -0.23% |
| 2018-07-31 | CA$-11.40 Million ≈ $-8.25 Million |
CA$-795.41K ≈ $-575.38K |
0.070x | -66.83% |
| 2017-07-31 | CA$-8.98 Million ≈ $-6.50 Million |
CA$-1.89 Million ≈ $-1.37 Million |
0.210x | -60.61% |
| 2016-07-31 | CA$-7.66 Million ≈ $-5.54 Million |
CA$-4.09 Million ≈ $-2.96 Million |
0.534x | +75.38% |
| 2015-07-31 | CA$-7.70 Million ≈ $-5.57 Million |
CA$-2.35 Million ≈ $-1.70 Million |
0.305x | -56.23% |
| 2014-07-31 | CA$-6.69 Million ≈ $-4.84 Million |
CA$-4.66 Million ≈ $-3.37 Million |
0.696x | +685.62% |
| 2011-07-31 | CA$-19.11 Million ≈ $-13.83 Million |
CA$-1.69 Million ≈ $-1.22 Million |
0.089x | -44.03% |
| 2010-07-31 | CA$-16.66 Million ≈ $-12.05 Million |
CA$-2.64 Million ≈ $-1.91 Million |
0.158x | +25.16% |
| 2009-07-31 | CA$-16.00 Million ≈ $-11.57 Million |
CA$-2.02 Million ≈ $-1.46 Million |
0.126x | -45.46% |
| 2008-07-31 | CA$-13.94 Million ≈ $-10.08 Million |
CA$-3.23 Million ≈ $-2.34 Million |
0.232x | +40.86% |
| 2007-07-31 | CA$-12.78 Million ≈ $-9.24 Million |
CA$-2.10 Million ≈ $-1.52 Million |
0.165x | -82.43% |
| 2006-07-31 | CA$-8.05 Million ≈ $-5.82 Million |
CA$-7.54 Million ≈ $-5.45 Million |
0.937x | +70.96% |
| 2005-07-31 | CA$-9.80 Million ≈ $-7.09 Million |
CA$-5.37 Million ≈ $-3.89 Million |
0.548x | +4.46% |
| 2004-07-31 | CA$-5.87 Million ≈ $-4.25 Million |
CA$-3.08 Million ≈ $-2.23 Million |
0.525x | -61.59% |
| 2003-07-31 | CA$-2.19 Million ≈ $-1.58 Million |
CA$-2.99 Million ≈ $-2.16 Million |
1.366x | +178.17% |
| 2002-07-31 | CA$-7.45 Million ≈ $-5.39 Million |
CA$-3.66 Million ≈ $-2.64 Million |
0.491x | -51.47% |
| 2001-07-31 | CA$-6.01 Million ≈ $-4.35 Million |
CA$-6.08 Million ≈ $-4.40 Million |
1.012x | +8.71% |
| 2000-07-31 | CA$-3.28 Million ≈ $-2.37 Million |
CA$-3.05 Million ≈ $-2.21 Million |
0.931x | -- |
About MedMira Inc
MedMira Inc., a biotechnology company, researches, develops, manufactures, and sells rapid diagnostics and technology platforms in North America, Europe, and internationally. The company offers Reveal HIV, a test that detects antibodies to HIV-1 and HIV-2 in whole blood, serum, or plasma; Reveal TP, a rapid syphilis antibody test that detects treponema pallidum antibodies in serum, plasma, or who… Read more